Skip to main content

NINE MASTS CAPITAL Ltd

Position in STLN — Starling Oncology, Inc.

CIK 1569356 CENTRAL, K3

Position in STLN

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$43,035
New position
Shares Held
14,018
first reported quarter
Ownership
0.014%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

All Filings in STLN

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-03-31 $43,035 14,018